Tag archive for ‘VBL’
Globes On Thursday, July 31st, 2014

VBL Therapeutics prices Nasdaq IPO

– The clinical stage biotech company is selling 5.4 million ordinary shares at $12 each. Clinical-stage biotech company VBL Therapeutics has announced the pricing of its Nasdaq IPO. The company is selling More...

Gali Weinreb On Wednesday, July 23rd, 2014

Flight Cancellations May Jeopardize Israeli Nasdaq IPOs

– Investors are already asking questions and taking an interest in the possibility of a postponement until the situation is clarified. – Six Israeli biomed companies which were about to go public More...

Jewish Business News Service On Thursday, November 28th, 2013

VBL Therapeutics Receives FDA Fast Track For Brain Cancer Drug

– The Company’s VB-111 is a gene therapy for prolonging the survival in patients with recurrent Glioblastoma Multiforme (rGBM), an aggressive form of brain cancer.   VBL Therapeutics announced More...

Wordpress site Developed by Fixing WordPress Problems